Exact Mass: 550.4233168000001
Exact Mass Matches: 550.4233168000001
Found 361 metabolites which its exact mass value is equals to given mass value 550.4233168000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
echinenone
A carotenone that is beta-carotene in which the 4 position has undergone formal oxidation to afford the corresponding ketone. Isolated as orange-red crystals, it is widely distributed in marine invertebrates. D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids Window width for selecting the precursor ion was 3 Da.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 16HP2005 to the Mass Spectrometry Society of Japan.
(3R,6'R)-3-Hydroxy-3',4'-didehydro-beta,gamma-carotene
(3R,6R)-3-Hydroxy-3,4-didehydro-β,γ-carotene is a carotenoid found in human serum and breast milk (PMID: 9164160). Carotenoids are isoprenoid molecules that are widespread in nature and are typically seen as pigments in fruits, flowers, birds and crustacea. Animals are unable to synthesise carotenoids de novo, and rely upon the diet as a source of these compounds. Over recent years there has been considerable interest in dietary carotenoids with respect to their potential in alleviating age-related diseases in humans. This attention has been mirrored by significant advances in cloning most of the carotenoid genes and in the genetic manipulation of crop plants with the intention of increasing levels in the diet. Studies have shown an inverse relationship between the consumption of certain fruits and vegetables and the risk of epithelial cancer. Since carotenoids are among the micronutrients found in cancer preventive foods, detailed qualitative and quantitative determination of these compounds, particularly in fruits and vegetables and in human plasma, have recently become increasingly important. (PMID: 1416048, 15003396)
3-cis-Hydroxy-b,e-Caroten-3'-one
cis-3-hydroxy-b,e-Caroten-3-one is a carotenoid found in human fluids. Carotenoids are isoprenoid molecules that are widespread in nature and are typically seen as pigments in fruits, flowers, birds and crustacea. Animals are unable to synthesise carotenoids de novo, and rely upon the diet as a source of these compounds. Over recent years there has been considerable interest in dietary carotenoids with respect to their potential in alleviating age-related diseases in humans. This attention has been mirrored by significant advances in cloning most of the carotenoid genes and in the genetic manipulation of crop plants with the intention of increasing levels in the diet. Studies have shown an inverse relationship between the consumption of certain fruits and vegetables and the risk of epithelial cancer. Since carotenoids are among the micronutrients found in cancer preventive foods, detailed qualitative and quantitative determination of these compounds, particularly in fruits and vegetables and in human plasma, have recently become increasingly important. (PMID: 1416048, 15003396).
2',3'-Anhydrolutein
2,3-Anhydrolutein is a carotenoid found in human serum and breast milk (PMID: 9164160). Carotenoids are isoprenoid molecules that are widespread in nature and are typically seen as pigments in fruits, flowers, birds and crustacea. Animals are unable to synthesise carotenoids de novo, and rely upon the diet as a source of these compounds. Over recent years there has been considerable interest in dietary carotenoids with respect to their potential in alleviating age-related diseases in humans. This attention has been mirrored by significant advances in cloning most of the carotenoid genes and in the genetic manipulation of crop plants with the intention of increasing levels in the diet. Studies have shown an inverse relationship between the consumption of certain fruits and vegetables and the risk of epithelial cancer. Since carotenoids are among the micronutrients found in cancer preventive foods, detailed qualitative and quantitative determination of these compounds, particularly in fruits and vegetables and in human plasma, have recently become increasingly important. (PMID: 1416048, 15003396)
2,4,4-Trimethyl-3-[3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexen-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohex-2-en-1-one
2-[[3-(Decanoylamino)-2-decoxy-propoxy]-hydroxy-phosphoryl]oxyethyl-trimethyl-ammonium
DG(10:0/20:3(6,8,11)-OH(5)/0:0)
DG(10:0/20:3(6,8,11)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:3(6,8,11)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:3(6,8,11)-OH(5)/10:0/0:0)
DG(20:3(6,8,11)-OH(5)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(6,8,11)-OH(5)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/20:3(6,8,11)-OH(5))
DG(10:0/0:0/20:3(6,8,11)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:3(6,8,11)-OH(5)/0:0/10:0)
DG(20:3(6,8,11)-OH(5)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(12:0/18:2(10E,12Z)+=O(9)/0:0)
DG(12:0/18:2(10E,12Z)+=O(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/18:2(10E,12Z)+=O(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(18:2(10E,12Z)+=O(9)/12:0/0:0)
DG(18:2(10E,12Z)+=O(9)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:2(10E,12Z)+=O(9)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(12:0/0:0/18:2(10E,12Z)+=O(9))
DG(12:0/0:0/18:2(10E,12Z)+=O(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(18:2(10E,12Z)+=O(9)/0:0/12:0)
DG(18:2(10E,12Z)+=O(9)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(12:0/18:2(9Z,11E)+=O(13)/0:0)
DG(12:0/18:2(9Z,11E)+=O(13)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/18:2(9Z,11E)+=O(13)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(18:2(9Z,11E)+=O(13)/12:0/0:0)
DG(18:2(9Z,11E)+=O(13)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:2(9Z,11E)+=O(13)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(12:0/0:0/18:2(9Z,11E)+=O(13))
DG(12:0/0:0/18:2(9Z,11E)+=O(13)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(18:2(9Z,11E)+=O(13)/0:0/12:0)
DG(18:2(9Z,11E)+=O(13)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(12:0/18:3(10,12,15)-OH(9)/0:0)
DG(12:0/18:3(10,12,15)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/18:3(10,12,15)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(18:3(10,12,15)-OH(9)/12:0/0:0)
DG(18:3(10,12,15)-OH(9)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:3(10,12,15)-OH(9)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(12:0/0:0/18:3(10,12,15)-OH(9))
DG(12:0/0:0/18:3(10,12,15)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(18:3(10,12,15)-OH(9)/0:0/12:0)
DG(18:3(10,12,15)-OH(9)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(12:0/18:3(9,11,15)-OH(13)/0:0)
DG(12:0/18:3(9,11,15)-OH(13)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/18:3(9,11,15)-OH(13)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(18:3(9,11,15)-OH(13)/12:0/0:0)
DG(18:3(9,11,15)-OH(13)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:3(9,11,15)-OH(13)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(12:0/0:0/18:3(9,11,15)-OH(13))
DG(12:0/0:0/18:3(9,11,15)-OH(13)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(18:3(9,11,15)-OH(13)/0:0/12:0)
DG(18:3(9,11,15)-OH(13)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/18:2(10E,12Z)+=O(9)/0:0)
DG(i-12:0/18:2(10E,12Z)+=O(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/18:2(10E,12Z)+=O(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(18:2(10E,12Z)+=O(9)/i-12:0/0:0)
DG(18:2(10E,12Z)+=O(9)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:2(10E,12Z)+=O(9)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/0:0/18:2(10E,12Z)+=O(9))
DG(i-12:0/0:0/18:2(10E,12Z)+=O(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(18:2(10E,12Z)+=O(9)/0:0/i-12:0)
DG(18:2(10E,12Z)+=O(9)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/18:2(9Z,11E)+=O(13)/0:0)
DG(i-12:0/18:2(9Z,11E)+=O(13)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/18:2(9Z,11E)+=O(13)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(18:2(9Z,11E)+=O(13)/i-12:0/0:0)
DG(18:2(9Z,11E)+=O(13)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:2(9Z,11E)+=O(13)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/0:0/18:2(9Z,11E)+=O(13))
DG(i-12:0/0:0/18:2(9Z,11E)+=O(13)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(18:2(9Z,11E)+=O(13)/0:0/i-12:0)
DG(18:2(9Z,11E)+=O(13)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/18:3(10,12,15)-OH(9)/0:0)
DG(i-12:0/18:3(10,12,15)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/18:3(10,12,15)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(18:3(10,12,15)-OH(9)/i-12:0/0:0)
DG(18:3(10,12,15)-OH(9)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:3(10,12,15)-OH(9)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/0:0/18:3(10,12,15)-OH(9))
DG(i-12:0/0:0/18:3(10,12,15)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(18:3(10,12,15)-OH(9)/0:0/i-12:0)
DG(18:3(10,12,15)-OH(9)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/18:3(9,11,15)-OH(13)/0:0)
DG(i-12:0/18:3(9,11,15)-OH(13)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/18:3(9,11,15)-OH(13)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(18:3(9,11,15)-OH(13)/i-12:0/0:0)
DG(18:3(9,11,15)-OH(13)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:3(9,11,15)-OH(13)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/0:0/18:3(9,11,15)-OH(13))
DG(i-12:0/0:0/18:3(9,11,15)-OH(13)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(18:3(9,11,15)-OH(13)/0:0/i-12:0)
DG(18:3(9,11,15)-OH(13)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
Calcium palmitate
C32H62CaO4 (550.4273761999999)
It is used as a food additive .
adhyperforin
alpha-Echinenone
Window width for selecting the precursor ion was 3 Da.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 16HP2005 to the Mass Spectrometry Society of Japan.
3-O-[beta-D-arabinopyranosyl-oxy]-cholest-5-ene-3beta,19,25-triol|junceelloside D
gorgostane-1alpha,3beta,5alpha,6beta,11alpha,12beta-hexol 12-acetate
(24S)-24-methylcholestane-3beta,5alpha,6beta,25xi,26-pentol-25,26-diacetate
Dihydrocyclomicrophyllidin-A|Dihydrocyclomicrophyllidin-A-benzoat
(24S)-ergostan-3beta,5alpha,6beta,18,25-pentaol 18,25-diacetate
4-keto-gamma-carotene|4-Keto-gamma-carotin|beta,psi-caroten-4-one|beta,psi-Carotin-4-on
(E)-3,4-didehydro-beta,psi-caroten-16-ol|(E)-3,4-Didehydro-beta,psi-carotin-16-ol|16-hydroxytorulene|all-E-3,4-didehydro-beta,psi-caroten-16-ol
Celaxanthin
Window width to select the precursor ion was 3 Da.; CONE_VOLTAGE was 10 V.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan.
2-[Hydroxy-[[2-(octadecoxymethyl)oxolan-2-yl]methoxy]phosphoryl]oxyethyl-trimethylazanium
C29H61NO6P+ (550.4236275999999)
2-[[(2R)-2-acetyloxy-3-[(Z)-octadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C28H57NO7P+ (550.3872441999999)
[(2S)-1-decanoyloxy-3-hydroxypropan-2-yl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate
[(2S)-2-decanoyloxy-3-hydroxypropyl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate
[(2R)-3-decanoyloxy-2-hydroxypropyl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate
[(2S)-3-decanoyloxy-2-hydroxypropyl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate
[(2S)-1-dodecanoyloxy-3-hydroxypropan-2-yl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate
[(2S)-2-dodecanoyloxy-3-hydroxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate
[(2R)-3-dodecanoyloxy-2-hydroxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate
[(2S)-3-dodecanoyloxy-2-hydroxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate
[(2S)-1-dodecanoyloxy-3-hydroxypropan-2-yl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate
[(2S)-2-dodecanoyloxy-3-hydroxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate
[(2R)-3-dodecanoyloxy-2-hydroxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate
[(2S)-3-dodecanoyloxy-2-hydroxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate
2-[hydroxy-[(2R)-2-hydroxy-3-[(Z)-icos-11-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
C28H57NO7P+ (550.3872441999999)
[3-Carboxy-2-[15-(3,4-dimethyl-5-pentylfuran-2-yl)pentadecanoyloxy]propyl]-trimethylazanium
2-[hydroxy-[2-hydroxy-3-[(E)-icos-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
C28H57NO7P+ (550.3872441999999)
1-[(7R)-7-(Acetyloxy)-4-hydroxy-4-oxo-3,5,9-trioxa-4lambda~5~-phosphapentacosan-1-yl]-1-methylpyrrolidin-1-ium
C28H57NO7P+ (550.3872441999999)
1-o-(cis-9-octadecenyl)-2-o-acetyl-sn-glycero-3-phosphocholine
C28H57NO7P+ (550.3872441999999)
2-[[(2R)-2-[(E)-but-2-enoyl]oxy-3-hexadecoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C28H57NO7P+ (550.3872441999999)
2-[hydroxy-[(2R)-2-hydroxy-3-[(Z)-icos-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
C28H57NO7P+ (550.3872441999999)
[3-Hydroxy-2-(octanoylamino)pentadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(pentanoylamino)octadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Butanoylamino)-3-hydroxynonadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Hexanoylamino)-3-hydroxyheptadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(nonanoylamino)tetradecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(propanoylamino)icosyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Heptanoylamino)-3-hydroxyhexadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(tetradecanoylamino)nonyl] 2-(trimethylazaniumyl)ethyl phosphate
(2-Acetamido-3-hydroxyhenicosyl) 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(undecanoylamino)dodecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Dodecanoylamino)-3-hydroxyundecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Decanoylamino)-3-hydroxytridecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(tridecanoylamino)decyl] 2-(trimethylazaniumyl)ethyl phosphate
2-[[2-acetyloxy-3-[(Z)-octadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C28H57NO7P+ (550.3872441999999)
[3-Hydroxy-2-(pentadecanoylamino)octyl] 2-(trimethylazaniumyl)ethyl phosphate
(1-heptanoyloxy-3-hydroxypropan-2-yl) (13Z,16Z)-tetracosa-13,16-dienoate
[1-hydroxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] (Z)-heptadec-9-enoate
(1-decanoyloxy-3-hydroxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate
(1-dodecanoyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate
(1-hydroxy-3-tridecanoyloxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate
(1-hydroxy-3-undecanoyloxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate
[1-hydroxy-3-[(Z)-pentadec-9-enoyl]oxypropan-2-yl] (Z)-hexadec-9-enoate
(1-hydroxy-3-pentadecanoyloxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate
[1-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (Z)-octadec-9-enoate
(1-hydroxy-3-tetradecanoyloxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate
(1-hydroxy-3-pentanoyloxypropan-2-yl) (15Z,18Z)-hexacosa-15,18-dienoate
(1-hydroxy-3-nonanoyloxypropan-2-yl) (13Z,16Z)-docosa-13,16-dienoate
[(2S)-1-hydroxy-3-[(E)-pentadec-9-enoyl]oxypropan-2-yl] (E)-hexadec-9-enoate
[O-[1-O-(1-Oxo-13-icocenyl)-L-glycero-3-phospho]choline]anion
C28H57NO7P+ (550.3872441999999)
[(2S)-1-hydroxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] (E)-heptadec-9-enoate
(3-hydroxy-2-pentadecanoyloxypropyl) (4E,7E)-hexadeca-4,7-dienoate
[(2S)-1-hydroxy-3-tridecanoyloxypropan-2-yl] (9E,12E)-octadeca-9,12-dienoate
2-[hydroxy-[3-hydroxy-2-[(Z)-icos-4-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
C28H57NO7P+ (550.3872441999999)
[(2S)-3-hydroxy-2-[(E)-pentadec-9-enoyl]oxypropyl] (E)-hexadec-9-enoate
[(2S)-3-hydroxy-2-tetradecanoyloxypropyl] (9E,12E)-heptadeca-9,12-dienoate
[(2S)-3-hydroxy-2-tridecanoyloxypropyl] (9E,12E)-octadeca-9,12-dienoate
[1-carboxy-3-[3-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium
[(2S)-1-hydroxy-3-undecanoyloxypropan-2-yl] (11E,14E)-icosa-11,14-dienoate
[(2S)-3-hydroxy-2-undecanoyloxypropyl] (11E,14E)-icosa-11,14-dienoate
[(2S)-3-hydroxy-2-[(E)-tetradec-9-enoyl]oxypropyl] (E)-heptadec-9-enoate
2-[hydroxy-[(2R)-2-hydroxy-3-[(E)-icos-11-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
C28H57NO7P+ (550.3872441999999)
[(2S)-1-hydroxy-3-tetradecanoyloxypropan-2-yl] (9E,12E)-heptadeca-9,12-dienoate
[1-carboxy-3-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-pentanoyloxypropoxy]propyl]-trimethylazanium
2-[[2-hexanoyloxy-3-[(Z)-tetradec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C28H57NO7P+ (550.3872441999999)
[1-carboxy-3-[3-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium
2-[[2-butanoyloxy-3-[(Z)-hexadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C28H57NO7P+ (550.3872441999999)
[1-carboxy-3-[2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxy-3-propanoyloxypropoxy]propyl]-trimethylazanium
2-[hydroxy-[2-hydroxy-3-[(Z)-icos-11-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
C28H57NO7P+ (550.3872441999999)
2-[[3-[(Z)-henicos-11-enoxy]-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C29H61NO6P+ (550.4236275999999)
2-[[2-heptanoyloxy-3-[(Z)-tridec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C28H57NO7P+ (550.3872441999999)
2-[[3-[(Z)-heptadec-9-enoxy]-2-propanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C28H57NO7P+ (550.3872441999999)
2-[hydroxy-[3-[(Z)-pentadec-9-enoxy]-2-pentanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
C28H57NO7P+ (550.3872441999999)
4-Hydroxy-8-methyl-1-(2-methylbutanoyl)-3,5,7-tris(3-methylbut-2-enyl)-8-(4-methylpent-3-enyl)bicyclo[3.3.1]non-3-ene-2,9-dione
1-tridecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycerol
1-(9Z-pentadecenoyl)-2-(9Z-hexadecenoyl)-sn-glycerol
1-tetradecanoyl-2-(9Z,12Z-heptadecadienoyl)-sn-glycerol
TG(31:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
TG(30:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(1r,3as,3bs,5s,5ar,7s,9s,9as,9bs,10s,11s,11ar)-5,5a,7,9,10-pentahydroxy-9a,11a-dimethyl-1-[(1r)-1-[(1r,2s)-2-methyl-2-[(2s)-3-methylbutan-2-yl]cyclopropyl]ethyl]-tetradecahydrocyclopenta[a]phenanthren-11-yl acetate
7,11,15,19-tetramethyl-2-[(1e,3e,5e,7e)-4,8,12-trimethyltrideca-1,3,5,7,11-pentaen-1-yl]icosa-2,4,6,8,10,12,14,18-octaenal
3-(3,7,12,16,20,24-hexamethylpentacosa-1,3,5,7,9,11,13,15,17,19,23-undecaen-1-yl)-2,4,4-trimethylcyclohex-2-en-1-one
(2e,16e,18e,20e,22e,24e)-2,10,14,19,23-pentamethyl-25-(2,6,6-trimethylcyclohex-1-en-1-yl)pentacosa-2,4,6,8,10,12,14,16,18,20,22,24-dodecaenoic acid
2,6,10,14,19,23-hexamethyl-25-(2,3,6-trimethylphenyl)pentacosa-6,8,10,12,14,16,18,20,22,24-decaen-2-ol
(1r)-4-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-[(1s)-6,6-dimethyl-2-methylidenecyclohex-3-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-ol
(3r)-3-{[(2s,4r,5s)-5-[(1r,2s,3as,3br,5as,7s,9as,9bs,11as)-2,7-dihydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-hydroxy-2,5-dimethyl-1,3-dioxolan-4-yl]methyl}-2-methylbutan-2-yl acetate
3,4-didehydroxy-3'-deoxycapsanthin
{"Ingredient_id": "HBIN007338","Ingredient_name": "3,4-didehydroxy-3'-deoxycapsanthin","Alias": "NA","Ingredient_formula": "C40H54O","Ingredient_Smile": "CC1=C(C(CC=C1)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC(=O)C2(CCCC2(C)C)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5471","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}